Research institute
A team led by Dr. Decio Eizirik, M.D., Ph.D., Scientific Director for Indiana Biosciences Research Institute Diabetes Center, has taken a step back from the traditional immune system study approach and found potential for treatment and, theoretically, even a cure.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 26, 2021.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 12, 2021.
Evidence continues to build for long-lasting immunity to COVID-19 following disease infection, with the publication of a new study showing a durable immune response as far as eight months after the initial onset of symptoms.
News, much of it good, keeps coming in about the efficacy of the various COVID-19 vaccines. Here’s a look.
NIH Director Francis Collins and David Liu of the Broad Institute have teamed up to conduct a study utilizing CRISPR, the genome-editing system, to see what they could do in terms of altering the aging process in mice.
2021 is off to a hopeful start for some companies, executives and scientists, while others are forced to fold programs and recalibrate.
Researchers with Shenzhen Institutes of Advanced Technology in China used a variety of computational techniques to simulate drug-virus interactions. They then screened 1,906 existing drugs to evaluate which ones might inhibit replication of SARS-CoV-2, the virus that causes COVID-19.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
PRESS RELEASES